Provided by Tiger Trade Technology Pte. Ltd.

Relay Therapeutics

19.44
-0.2600-1.32%
Post-market: 19.500.0600+0.31%19:56 EDT
Volume:2.97M
Turnover:58.13M
Market Cap:4.26B
PE:-12.42
High:20.17
Open:19.92
Low:19.18
Close:19.70
52wk High:21.27
52wk Low:3.43
Shares:219.14M
Float Shares:145.00M
Volume Ratio:1.41
T/O Rate:2.05%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.5651
EPS(LYR):-1.6113
ROE:-36.77%
ROA:-22.88%
PB:4.79
PE(LYR):-12.06

Loading ...

Relay Therapeutics Expands Authorized Shares at 2026 Meeting

TIPRANKS
·
Jun 10

Relay Therapeutics shareholders approve increase in authorized common shares to 450 million

Reuters
·
Jun 10

Analysts Conflicted on These Healthcare Names: Arvinas Holding Company (ARVN), Lyell Immunopharma (LYEL) and Relay Therapeutics (RLAY)

TIPRANKS
·
Jun 03

Analysts Are Bullish on These Healthcare Stocks: Rezolute (RZLT), Relay Therapeutics (RLAY)

TIPRANKS
·
Jun 03

Relay Therapeutics to Participate in Two Upcoming Investor Conferences in June

GlobeNewswire
·
May 28

Relay Therapeutics price target raised to $26 from $22 at Guggenheim

TIPRANKS
·
May 26

Relay Therapeutics Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
May 26

Relay Therapeutics (RLAY) Is Up 6.9% After Zovegalisib Phase 2 Data And Equity Raise - Has The Bull Case Changed?

Simply Wall St.
·
May 22

BUZZ-U.S. STOCKS ON THE MOVE-Keysight Technologies, Relay Therapeutics, Ralph Lauren

Reuters
·
May 21

BUZZ-Relay Therapeutics gains after $275 mln equity raise

Reuters
·
May 21

Relay Therapeutics Prices $275 Million Public Offering

MT Newswires Live
·
May 21

BRIEF-Relay Therapeutics Announces Pricing Of Public Offering Of Common Stock

Reuters
·
May 21

Relay Therapeutics prices 22,916,667-share follow-on offering at $12 per share

Reuters
·
May 21

Relay Therapeutics Inc - Prices Public Offering of 22,916,667 Shares at $12.00 per Share

THOMSON REUTERS
·
May 21

Relay Therapeutics Announces Pricing of Public Offering of Common Stock

THOMSON REUTERS
·
May 21

BUZZ-Relay jumps on promising vascular disorder drug data

Reuters
·
May 21

Relay Therapeutics Is Maintained at Market Outperform by Citizens

Dow Jones
·
May 20

Goldman Sachs Sticks to Their Buy Rating for Relay Therapeutics (RLAY)

TIPRANKS
·
May 20

Relay Therapeutics price target raised to $21 from $19 at Citizens

TIPRANKS
·
May 20

Analysts Offer Insights on Healthcare Companies: Relay Therapeutics (RLAY) and Wave Life Sciences (WVE)

TIPRANKS
·
May 20